Humabiologics, LLC is a regenerative medicine startup company founded by scientists and tissue industry experts with scientific, quality, regulatory and technology transfer expertise to address the gap between the gift of donated human tissues and researchers.
Humabiologics is dedicated to stretching the gift of donation by developing and commercializing high quality, supply stable and affordable human-derived biomaterials from tissue and organs for regenerative medicine therapies that complies with the FDA's 21 CFR 1271 regulation and the tissue industry quality system standards. Humabiologics partners with academic and industry institutions to develop human-derived biomaterials for researchers to innovate regenerative medicine therapies to address debilitating diseases and improve the quality of life for patients.
By stretching the gift of donation, they strive to help as many people as possible with their unique products to empower tomorrow's innovations. Their products can be used alone or in conjunction with other biomaterials in various fields including tissue engineering, regenerative medicine, 3D bioprinting, diagnostics & screening, pharmacology, cell culture, and many other life sciences applications.